CD47 and neoplasm: Finally, pharmacologic or genetic CD47 inhibition in subcutaneous mouse tumors growing in immunocompetent mice still led to enhanced tumor inhibition following irradiation, indicating that the antitumor effects observed are not adversely affected by the presence of T cells, B cells or NK cells (Fig. 1g–i).